Cent infections. AIDS Res Hum Retroviruses. 2009;25:93?02. 19. Kousiappa I, Van De Vijver
Cent infections. AIDS Res Hum Retroviruses. 2009;25:93?02. 19. Kousiappa I, Van De Vijver DA, Kostrikis LG. Near full-length genetic analysis of HIV sequences derived from Cyprus: evidence of a highly polyphyletic and evolving infection. AIDS Res Hum Retroviruses. 2009;25:727?0. 20. Sanabani SS, Pessoa R, Soares de Oliveira AC, Martinez VP, Giret MT, de Menezes Succi RC, et al. Variability of HIV-1 genomes among children and adolescents from Sao Paulo, Brazil. PLoS One. 2013;8:e62552. 21. Fernandez-Garcia A, Revilla A, Vazquez-de Parga E, Vinogradova A, Rakhmanova A, Karamov E, et al. The analysis of near full-length genome sequences of HIV type 1 subtype A viruses from Russia supports the monophyly of major intrasubtype clusters. AIDS Res Hum Retroviruses. 2012;28:1340?. 22. Henn MR, Boutwell CL, Charlebois P, Lennon NJ, Power KA, Macalalad AR, et al. Whole genome deep sequencing of HIV-1 reveals the impact of early minor variants upon immune recognition during acute infection. PLoS Pathog. 2012;8:e1002529. 23. Guyader M, Emerman M, Sonigo P, Clavel F, Montagnier L, Alizon M. Genome organization and transactivation of the human immunodeficiency virus type 2. Nature. 1987;326:662?. 24. Korber B, Gaschen B, Yusim K, Thakallapally R, Kesmir C, PubMed ID:https://www.ncbi.nlm.nih.gov/pubmed/28494239 Detours V. Evolutionary and immunological implications of contemporary HIV-1 variation. Br Med Bull. 2001;58:19?2. 25. van der Kuyl AC, Berkhout B. The biased nucleotide composition of the HIV genome: a constant factor in a highly variable virus. Retrovirology. 2012;9:92. 26. Snoeck J, Fellay J, Bartha I, Douek DC, Telenti A. Mapping of positive selection sites in the HIV-1 genome in the context of RNA and protein structural constraints. Retrovirology. 2011;8:87. 27. Mayrose I, Stern A, Burdelova EO, Sabo Y, Laham-Karam N, Zamostiano R, et al. Synonymous site conservation in the HIV-1 genome. BMC Evol Biol. 2013;13:164. 28. Santoro MM, Perno CF. HIV-1 Genetic Variability and Clinical Implications. ISRN Microbiol. 2013;2013:481314. 29. Hemelaar J, Gouws E, Ghys PD, Osmanov S. Isolation W-UNfH, Characterisation: Global Olumacostat glasaretil chemical information Trends in molecular epidemiology of HIV-1 during 2000-2007. AIDS. 2011;25:679?9. 30. Xue B, Mizianty MJ, Kurgan L, Uversky VN. Protein intrinsic disorder as a flexible armor and a weapon of HIV-1. Cell Mol Life Sci. 2012;69:1211?9. 31. Haynes BF, Gilbert PB, McElrath MJ, Zolla-Pazner S, Tomaras GD, Alam SM, et al. Immune-correlates analysis of an HIV-1 vaccine efficacy trial. Engl J Med. 2012;366:1275?6. 32. Boons E, Li G, Vanstreels E, Vercruysse T, Pannecouque C, Vandamme A-M, et al. A stably expressed llama single-domain intrabody targeting Rev displays broad-spectrum anti-HIV activity. Antiviral Research. 2014;112:91?02. 33. PubMed ID:https://www.ncbi.nlm.nih.gov/pubmed/26100631 Rambaut A, Posada D, Crandall KA, Holmes EC. The causes and consequences of HIV evolution. Nat Rev Genet. 2004;5:52?1. 34. Falkowski PG, Fenchel T, Delong EF. The microbial engines that drive Earth’s biogeochemical cycles. Science. 2008;320:1034?. 35. Dunwell JM, Culham A, Carter CE, Sosa-Aguirre CR, Goodenough PW. Evolution of functional diversity in the cupin superfamily. Trends Biochem Sci. 2001;26:740?. 36. Buck PM, Kumar S, Singh SK. On the role of aggregation prone regions in protein evolution, stability, and enzymatic catalysis: insights from diverse analyses. PLoS Comput Biol. 2013;9:e1003291.Li et al. Retrovirology (2015) 12:Page 17 of37. Li G, Theys K, Verheyen J, Pineda-Pena A, Khouri R, Piampongsant S, et al. A new ensemble coevolution system for det.